Status:
COMPLETED
Sugammadex and Brain Waves
Lead Sponsor:
Tampere University Hospital
Conditions:
Anaesthesia
Eligibility:
FEMALE
18-65 years
Phase:
PHASE4
Brief Summary
According to our experience, electroencephalogram-based indices of anaesthetic state show elevated numbers after administration of sugammadex (new reversal of neuromuscular blockade). This can be due ...
Detailed Description
Rocuronium-induced neuromuscular blockade is antagonized with sugammadex or neostigmine. BIS, Entropy and the biosignal collected from the Entropy strip are collected on computer. The behaviour of the...
Eligibility Criteria
Inclusion
- females giving informed consent
- age range 18-65 years
- elective surgery: gynaecological
- general anaesthesia
- ASA classification 1 or 2
Exclusion
- pregnancy
- body mass index \> 30
- disease affecting CNS
- overuse of alcohol
- drug abuse
- unability to understand, read or use Finnish language
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01142648
Start Date
April 1 2009
End Date
March 1 2010
Last Update
June 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital
Tampere, Finland